Skip to content

Coronavirus Special Report: What’s next for the surplus of hydroxychloroquine?

Bottles of hydroxychloroquine pills wait to be distributed in hospitals in San Salvador, El Salvador, on April 21.
Bottles of hydroxychloroquine pills wait to be distributed in hospitals in San Salvador, El Salvador, on April 21. (Yuri Cortez/AFP via Getty Images file photo)

In tonight’s podcast, we delve into the latest in health policy news: What will states that purchased the malaria drug hydroxychloroquine do with their supplies of the increasingly discredited COVID-19 treatment option? And what should we expect from Dr. Anthony Fauci’s Senate testimony next week? Also, Republican lawmakers reckon with oversight.

Recent Stories

Houchin looks to push kids social media ban in lame duck

Army findings inject urgency into air safety bill talks

Plan for public military execution sparks bipartisan backlash

Cyber information-sharing law stuck in Senate stalemate

The anthrax attacks, 25 years later 

Replacing Alito on the court? It’s if, not when